ERRATUM: Valentine V, Hinnen D. Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes. Clinical Diabetes 2014;33:5–13 (DOI: 10.2337/diaclin.33.2.96)
In the print version of the article listed above, there is an inconsistency in Table 1 on page 8. The weights given in the row summarizing changes in body weight should have been provided in kilograms instead of pounds, given that all weight data discussed in the article was expressed as kilograms. The corrected table row appears below:
View this table:
TABLE 1.
Summary of Efficacy and Safety of Canagliflozin as Add-On to Metformin, Metformin Plus Sulfonylurea, and Insulin in Patients With Type 2 Diabetes Over 52 Weeks (3,30–33,50,53)
The online version reflects these changes.
- © 2015 by the American Diabetes Association.
In this Issue
April 2015, 33(2)
ERRATUM: Valentine V, Hinnen D. Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes. Clinical Diabetes 2014;33:5–13 (DOI: 10.2337/diaclin.33.2.96)
